Indrajanu Intan Nurani, Marhana Isnin Anang, Indrawanto Dwi Wahyu
Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Airlangga - Dr. Soetomo General Academic Hospital, Surabaya, Indonesia.
Respir Med Case Rep. 2024 Jun 21;51:102079. doi: 10.1016/j.rmcr.2024.102079. eCollection 2024.
Synovial sarcoma is a rare and aggressive tumor that primarily affects soft tissues, including the mediastinum, and predominantly affects younger adults. A 23-year-old male patient with mediastinal synovial sarcoma underwent debulking surgery and received 3 cycles of doxorubicin, ifosfamide, and mesna chemotherapy. Mediastinal synovial sarcoma presents diagnostic challenges and poor prognosis. Treatment involves surgical resection, adjuvant chemotherapy, and radiotherapy. Mediastinal synovial sarcoma can be diagnosed through histopathological and immunohistochemical examination. Adjuvant chemotherapy led to a partial response, showing a decrease in tumor size and resolution of pleural effusion, demonstrating a positive interim outcome.
滑膜肉瘤是一种罕见且侵袭性强的肿瘤,主要累及包括纵隔在内的软组织,且主要影响年轻成年人。一名患有纵隔滑膜肉瘤的23岁男性患者接受了减瘤手术,并接受了3个周期的多柔比星、异环磷酰胺和美司钠化疗。纵隔滑膜肉瘤存在诊断挑战且预后较差。治疗包括手术切除、辅助化疗和放疗。纵隔滑膜肉瘤可通过组织病理学和免疫组织化学检查进行诊断。辅助化疗产生了部分缓解,表现为肿瘤大小减小和胸腔积液消退,显示出积极的中期结果。